Answer
Screening for HIV, active hepatitis B virus (HBV) and active hepatitis C virus (HCV) must be performed before cells are collected to manufacture Breyanzi (lisocabtagene maraleucel).
Sources for this answer
- Breyanzi 1.1-70 × 10^6 cells/mL / 1.1-70 × 10^6 cells/mL dispersion for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked